EquityZen Growth Technology Fund II LLC - Series 21
Raised
$4M
Investors
33
Min Invest
$100,127
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund II LLC - Series 21 is a Delaware-organized pooled investment fund filed by EquityZen Advisors LLC and executive Phil Haslett. The fund raised $3.6M from 33 investors under Rule 506(b) and 3(c) exemptions with a $100K minimum investment. This is part of the EquityZen platform, which operates approximately 150 related EDGAR entities focused on private equity investments.
This filing represents a typical mid-size private equity SPV structure using 506(b) and 3(c) exemptions, consistent with accredited-investor-only pooled vehicles. The $100K minimum investment and $3.6M total raise indicate a professionally managed series offering targeting qualified institutional and individual investors, typical of secondary market platform funds in the growth technology sector.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Phil Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. AltStreet analysis (summaries, flags, category context) is generated by Claude from this primary source data and reviewed for accuracy. Platform-provided information (if present) is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. EDGAR data is verified read-only — platforms may request factual corrections for demonstrable inaccuracies by contacting research@altstreet.investments. This page does not constitute investment advice.
